0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
China Antivenom Market Report & Forecast 2021-2027
Published Date: October 2021
|
Report Code: QYRE-Auto-779
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
China Antivenom Market Report Forecast 2021 2027

China Antivenom Market Report & Forecast 2021-2027

Code: QYRE-Auto-779
Report
October 2021
90 Pages
QYResearch
Region: Global, Africa, Europe, North America, Asia Pacific, Middle East, China,
Description
Table of Content
Tables & Figures
China Antivenom Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Vials)
China Antivenom Market Segment Percentages, By Type, 2020 (%)
Polyvalent antivenom
Monovalent antivenom
China Antivenom Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Vials)
China Antivenom Market Segment Percentages, By Application, 2020 (%)
Non-profit Institutions
Hospitals and Clinic
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antivenom revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Antivenom revenues share in China market, 2020 (%)
Key companies Antivenom sales in China market, 2016-2021 (Estimated), (K Vials)
Key companies Antivenom sales share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
1 Introduction to Research & Analysis Reports
1.1 Antivenom Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Antivenom Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Antivenom Overall Market Size
2.1 China Antivenom Market Size: 2021 VS 2027
2.2 China Antivenom Revenue, Prospects & Forecasts: 2016-2027
2.3 China Antivenom Sales: 2016-2027
3 Company Landscape
3.1 Top Antivenom Players in China Market
3.2 Top China Antivenom Companies Ranked by Revenue
3.3 China Antivenom Revenue by Companies
3.4 China Antivenom Sales by Companies
3.5 China Antivenom Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Antivenom Companies in China Market, by Revenue in 2020
3.7 Manufacturers Antivenom Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antivenom Players in China Market
3.8.1 List of Tier 1 Antivenom Companies in China
3.8.2 List of Tier 2 and Tier 3 Antivenom Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Antivenom Market Size Markets, 2021 & 2027
4.1.2 Polyvalent antivenom
4.1.3 Monovalent antivenom
4.2 By Type - China Antivenom Revenue & Forecasts
4.2.1 By Type - China Antivenom Revenue, 2016-2021
4.2.2 By Type - China Antivenom Revenue, 2022-2027
4.2.3 By Type - China Antivenom Revenue Market Share, 2016-2027
4.3 By Type - China Antivenom Sales & Forecasts
4.3.1 By Type - China Antivenom Sales, 2016-2021
4.3.2 By Type - China Antivenom Sales, 2022-2027
4.3.3 By Type - China Antivenom Sales Market Share, 2016-2027
4.4 By Type - China Antivenom Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Antivenom Market Size, 2021 & 2027
5.1.2 Non-profit Institutions
5.1.3 Hospitals and Clinic
5.2 By Application - China Antivenom Revenue & Forecasts
5.2.1 By Application - China Antivenom Revenue, 2016-2021
5.2.2 By Application - China Antivenom Revenue, 2022-2027
5.2.3 By Application - China Antivenom Revenue Market Share, 2016-2027
5.3 By Application - China Antivenom Sales & Forecasts
5.3.1 By Application - China Antivenom Sales, 2016-2021
5.3.2 By Application - China Antivenom Sales, 2022-2027
5.3.3 By Application - China Antivenom Sales Market Share, 2016-2027
5.4 By Application - China Antivenom Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 CSL
6.1.1 CSL Corporation Information
6.1.2 CSL Overview
6.1.3 CSL Antivenom Sales and Revenue in China Market (2016-2021)
6.1.4 CSL Antivenom Product Description
6.1.5 CSL Recent Developments
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Overview
6.2.3 Merck Antivenom Sales and Revenue in China Market (2016-2021)
6.2.4 Merck Antivenom Product Description
6.2.5 Merck Recent Developments
6.3 BTG
6.3.1 BTG Corporation Information
6.3.2 BTG Overview
6.3.3 BTG Antivenom Sales and Revenue in China Market (2016-2021)
6.3.4 BTG Antivenom Product Description
6.3.5 BTG Recent Developments
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Overview
6.4.3 Pfizer Antivenom Sales and Revenue in China Market (2016-2021)
6.4.4 Pfizer Antivenom Product Description
6.4.5 Pfizer Recent Developments
6.5 Haffkine Bio-Pharmaceutical
6.5.1 Haffkine Bio-Pharmaceutical Corporation Information
6.5.2 Haffkine Bio-Pharmaceutical Overview
6.5.3 Haffkine Bio-Pharmaceutical Antivenom Sales and Revenue in China Market (2016-2021)
6.5.4 Haffkine Bio-Pharmaceutical Antivenom Product Description
6.5.5 Haffkine Bio-Pharmaceutical Recent Developments
6.6 Rare Disease Therapeutics
6.6.1 Rare Disease Therapeutics Corporation Information
6.6.2 Rare Disease Therapeutics Overview
6.6.3 Rare Disease Therapeutics Antivenom Sales and Revenue in China Market (2016-2021)
6.6.4 Rare Disease Therapeutics Antivenom Product Description
6.6.5 Rare Disease Therapeutics Recent Developments
6.7 Flynn Pharma
6.7.1 Flynn Pharma Corporation Information
6.7.2 Flynn Pharma Overview
6.7.3 Flynn Pharma Antivenom Sales and Revenue in China Market (2016-2021)
6.7.4 Flynn Pharma Antivenom Product Description
6.7.5 Flynn Pharma Recent Developments
6.8 Vins Bioproducts
6.8.1 Vins Bioproducts Corporation Information
6.8.2 Vins Bioproducts Overview
6.8.3 Vins Bioproducts Antivenom Sales and Revenue in China Market (2016-2021)
6.8.4 Vins Bioproducts Antivenom Product Description
6.8.5 Vins Bioproducts Recent Developments
6.9 Bharat Serums and Vaccines
6.9.1 Bharat Serums and Vaccines Corporation Information
6.9.2 Bharat Serums and Vaccines Overview
6.9.3 Bharat Serums and Vaccines Antivenom Sales and Revenue in China Market (2016-2021)
6.9.4 Bharat Serums and Vaccines Antivenom Product Description
6.9.5 Bharat Serums and Vaccines Recent Developments
6.10 Serum Biotech
6.10.1 Serum Biotech Corporation Information
6.10.2 Serum Biotech Overview
6.10.3 Serum Biotech Antivenom Sales and Revenue in China Market (2016-2021)
6.10.4 Serum Biotech Antivenom Product Description
6.10.5 Serum Biotech Recent Developments
6.11 MicroPharm
6.11.1 MicroPharm Corporation Information
6.11.2 MicroPharm Overview
6.11.3 MicroPharm Antivenom Sales and Revenue in China Market (2016-2021)
6.11.4 MicroPharm Antivenom Product Description
6.11.5 MicroPharm Recent Developments
7 China Antivenom Production Capacity, Analysis
7.1 China Antivenom Production Capacity, 2016-2027
7.2 Antivenom Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Antivenom Supply Chain Analysis
9.1 Antivenom Industry Value Chain
9.2 Antivenom Upstream Market
9.3 Antivenom Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Antivenom Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
    Table 1. Key Players of Antivenom in China Market
    Table 2. Top Antivenom Players in China Market, Ranking by Revenue (2019)
    Table 3. China Antivenom Revenue by Companies, (US$, Mn), 2016-2021
    Table 4. China Antivenom Revenue Share by Companies, 2016-2021
    Table 5. China Antivenom Sales by Companies, (K Vials), 2016-2021
    Table 6. China Antivenom Sales Share by Companies, 2016-2021
    Table 7. Key Manufacturers Antivenom Price (2016-2021) & (USD/Vial)
    Table 8. Manufacturers Antivenom Product Type
    Table 9. List of Tier 1 Antivenom Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Tier 2 and Tier 3 Antivenom Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. Major Manufacturers of Polyvalent antivenom
    Table 12. Major Manufacturers of Monovalent antivenom
    Table 13. By Type – China Antivenom Revenue, (US$, Mn), 2021 & 2027
    Table 14. By Type - China Antivenom Revenue (US$, Mn), 2016-2021
    Table 15. By Type - China Antivenom Revenue (US$, Mn), 2022-2027
    Table 16. By Type - China Antivenom Sales (K Vials), 2016-2021
    Table 17. By Type - China Antivenom Sales (K Vials), 2022-2027
    Table 18. By Application – China Antivenom Revenue, (US$, Mn), 2021 VS 2027
    Table 19. By Application - China Antivenom Revenue (US$, Mn), 2016-2021
    Table 20. By Application - China Antivenom Revenue (US$, Mn), 2022-2027
    Table 21. By Application - China Antivenom Sales (K Vials), 2016-2021
    Table 22. By Application - China Antivenom Sales (K Vials), 2022-2027
    Table 23. CSL Corporation Information
    Table 24. CSL Description and Major Businesses
    Table 25. CSL Antivenom Sales (K Vials), Revenue (US$, Mn) and Gross Margin (USD/Vial) (2016-2021)
    Table 26. CSL Antivenom Product
    Table 27. CSL Recent Developments
    Table 28. Merck Corporation Information
    Table 29. Merck Description and Major Businesses
    Table 30. Merck Antivenom Sales (K Vials), Revenue (US$, Mn) and Gross Margin (USD/Vial) (2016-2021)
    Table 31. Merck Antivenom Product
    Table 32. Merck Recent Developments
    Table 33. BTG Corporation Information
    Table 34. BTG Description and Major Businesses
    Table 35. BTG Antivenom Sales (K Vials), Revenue (US$, Mn) and Gross Margin (USD/Vial) (2016-2021)
    Table 36. BTG Antivenom Product
    Table 37. BTG Recent Developments
    Table 38. Pfizer Corporation Information
    Table 39. Pfizer Description and Major Businesses
    Table 40. Pfizer Antivenom Sales (K Vials), Revenue (US$, Mn) and Gross Margin (USD/Vial) (2016-2021)
    Table 41. Pfizer Antivenom Product
    Table 42. Pfizer Recent Developments
    Table 43. Haffkine Bio-Pharmaceutical Corporation Information
    Table 44. Haffkine Bio-Pharmaceutical Description and Major Businesses
    Table 45. Haffkine Bio-Pharmaceutical Antivenom Sales (K Vials), Revenue (US$, Mn) and Gross Margin (USD/Vial) (2016-2021)
    Table 46. Haffkine Bio-Pharmaceutical Antivenom Product
    Table 47. Haffkine Bio-Pharmaceutical Recent Developments
    Table 48. Rare Disease Therapeutics Corporation Information
    Table 49. Rare Disease Therapeutics Description and Major Businesses
    Table 50. Rare Disease Therapeutics Antivenom Sales (K Vials), Revenue (US$, Mn) and Gross Margin (USD/Vial) (2016-2021)
    Table 51. Rare Disease Therapeutics Antivenom Product
    Table 52. Rare Disease Therapeutics Recent Developments
    Table 53. Flynn Pharma Corporation Information
    Table 54. Flynn Pharma Description and Major Businesses
    Table 55. Flynn Pharma Antivenom Sales (K Vials), Revenue (US$, Mn) and Gross Margin (USD/Vial) (2016-2021)
    Table 56. Flynn Pharma Antivenom Product
    Table 57. Flynn Pharma Recent Developments
    Table 58. Vins Bioproducts Corporation Information
    Table 59. Vins Bioproducts Description and Major Businesses
    Table 60. Vins Bioproducts Antivenom Sales (K Vials), Revenue (US$, Mn) and Gross Margin (USD/Vial) (2016-2021)
    Table 61. Vins Bioproducts Antivenom Product
    Table 62. Vins Bioproducts Recent Developments
    Table 63. Bharat Serums and Vaccines Corporation Information
    Table 64. Bharat Serums and Vaccines Description and Major Businesses
    Table 65. Bharat Serums and Vaccines Antivenom Sales (K Vials), Revenue (US$, Mn) and Gross Margin (USD/Vial) (2016-2021)
    Table 66. Bharat Serums and Vaccines Antivenom Product
    Table 67. Bharat Serums and Vaccines Recent Developments
    Table 68. Serum Biotech Corporation Information
    Table 69. Serum Biotech Description and Major Businesses
    Table 70. Serum Biotech Antivenom Sales (K Vials), Revenue (US$, Mn) and Gross Margin (USD/Vial) (2016-2021)
    Table 71. Serum Biotech Antivenom Product
    Table 72. Serum Biotech Recent Developments
    Table 73. MicroPharm Corporation Information
    Table 74. MicroPharm Description and Major Businesses
    Table 75. MicroPharm Antivenom Sales (K Vials), Revenue (US$, Mn) and Gross Margin (USD/Vial) (2016-2021)
    Table 76. MicroPharm Antivenom Product
    Table 77. MicroPharm Recent Developments
    Table 78. Antivenom Production Capacity (K Vials) of Key Manufacturers in China Market, 2019-2021 (K Vials)
    Table 79. China Antivenom Capacity Market Share of Key Manufacturers, 2019-2021
    Table 80. Antivenom Market Opportunities & Trends in China Market
    Table 81. Antivenom Market Drivers in China Market
    Table 82. Antivenom Market Restraints in China Market
    Table 83. Antivenom Raw Materials
    Table 84. Antivenom Raw Materials Suppliers in China Market
    Table 85. Typical Antivenom Downstream
    Table 86. Antivenom Downstream Clients in China Market
    Table 87. Antivenom Distributors and Sales Agents in China Market
List of Figures
    Figure 1. Antivenom Product Picture
    Figure 2. Antivenom Segment by Type
    Figure 3. Antivenom Segment by Application
    Figure 4. China Antivenom Market Overview: 2020
    Figure 5. China Antivenom Market Size: 2021 VS 2027 (US$, Mn)
    Figure 6. China Antivenom Revenue, 2016-2027 (US$, Mn)
    Figure 7. Antivenom Sales in China Market: 2016-2027 (K Vials)
    Figure 8. The Top 3 and 5 Players Market Share by Antivenom Revenue in 2020
    Figure 9. Polyvalent antivenom Product Picture
    Figure 10. Monovalent antivenom Product Picture
    Figure 11. By Type - China Antivenom Sales Market Share, 2016-2027
    Figure 12. By Type - China Antivenom Revenue Market Share, 2016-2027
    Figure 13. By Type - China Antivenom Price (USD/Vial), 2016-2027
    Figure 14. Non-profit Institutions
    Figure 15. Hospitals and Clinic
    Figure 16. By Application - China Antivenom Sales Market Share, 2016-2027
    Figure 17. By Application - China Antivenom Revenue Market Share, 2016-2027
    Figure 18. By Application - China Antivenom Price (USD/Vial), 2016-2027
    Figure 19. CSL Antivenom Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 20. Merck Antivenom Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 21. BTG Antivenom Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 22. Pfizer Antivenom Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 23. Haffkine Bio-Pharmaceutical Antivenom Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 24. Rare Disease Therapeutics Antivenom Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 25. Flynn Pharma Antivenom Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 26. Vins Bioproducts Antivenom Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 27. Bharat Serums and Vaccines Antivenom Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 28. Serum Biotech Antivenom Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 29. MicroPharm Antivenom Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 30. China Antivenom Production Capacity (K Vials), 2016-2027
    Figure 31. Antivenom Industry Value Chain
    Figure 32. Marketing Channels
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3400
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$5100
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$6800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture

RELATED REPORTS

Global and China Membrane Bioreactor MBR Systems Market Insights Forecast to 2027
Global and China Membrane Bioreactor (MBR) Systems Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-24N7565
Tue Nov 30 00:00:00 UTC 2021

Add to Cart

Global and China Oligonucleotide API Market Insights Forecast to 2027
Global and China Oligonucleotide API Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-34J7553
Tue Nov 30 00:00:00 UTC 2021

Add to Cart

Global and Japan Prokaryotic Recombinant Protein Market Insights Forecast to 2027
Global and Japan Prokaryotic Recombinant Protein Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-20U7714
Tue Nov 30 00:00:00 UTC 2021

Add to Cart

Global and China Lentiviral Vector In Gene Therapy Market Insights Forecast to 2027
Global and China Lentiviral Vector In Gene Therapy Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-30V7563
Tue Nov 30 00:00:00 UTC 2021

Add to Cart